John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVB
476
DELISTED
AvalonBay Communities
AVB
| $14.2M | 0.04% |
88,680
-12,726
| -13% | -$2.02M |
|
477
Silicon Motion
SIMO
$8.14B
| $14.1M | 0.04% |
292,963
-41,105
| -12% | -$1.68M |
|
478
CALL
Teladoc Health
TDOC
$1.15B
| $14.1M | 0.04% |
70,400
-13,000
| -16% | -$2.64M |
|
479
Upwork
UPWK
$1.08B
| $14M | 0.04% |
406,184
+327,600
| +417% | +$9.37M |
|
480
CALL
Advanced Micro Devices
AMD
$747B
| $13.9M | 0.04% |
152,100
-254,200
| -63% | -$21.9M |
|
|
SWCH
481
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $13.9M | 0.04% |
851,607
+176,729
| +26% | +$2.76M |
|
482
Booz Allen Hamilton
BAH
$9.21B
| $13.9M | 0.04% |
+159,660
| New | +$13.6M |
|
483
RB Global
RBA
$15.8B
| $13.9M | 0.04% |
199,717
+57,973
| +41% | +$3.84M |
|
484
F5
FFIV
$21.5B
| $13.8M | 0.04% |
78,358
+41,791
| +114% | +$6.34M |
|
485
TC Energy
TRP
$64B
| $13.8M | 0.04% |
+338,251
| New | +$14.4M |
|
486
Children's Place
PLCE
$60.5M
| $13.6M | 0.04% |
+271,800
| New | +$9.89M |
|
487
CALL
PepsiCo
PEP
$198B
| $13.6M | 0.04% |
91,700
+14,800
| +19% | +$2.1M |
|
|
NGD
488
DELISTED
New Gold Inc
NGD
| $13.5M | 0.04% |
6,170,358
+3,456,722
| +127% | +$7.03M |
|
489
Main Street Capital
MAIN
$5.49B
| $13.4M | 0.04% |
414,997
+255,634
| +160% | +$7.85M |
|
490
Intuitive Surgical
ISRG
$133B
| $13.4M | 0.04% |
49,002
-71,148
| -59% | -$17.7M |
|
|
BRSL
491
Brightstar Lottery PLC
BRSL
$2.21B
| $13.3M | 0.04% |
+785,539
| New | +$9.59M |
|
492
Viasat
VSAT
$10.1B
| $13.3M | 0.04% |
406,642
-256,002
| -39% | -$8.8M |
|
493
Keysight
KEYS
$52.8B
| $13.3M | 0.04% |
+100,355
| New | +$11.6M |
|
494
PUT
AbbVie
ABBV
$466B
| $13.2M | 0.04% |
123,600
-58,100
| -32% | -$5.58M |
|
495
Syndax Pharmaceuticals
SNDX
$1.75B
| $13.2M | 0.04% |
594,871
+368,182
| +162% | +$7.64M |
|
496
Equinox Gold
EQX
$16B
| $13.2M | 0.04% |
1,275,840
-640,000
| -33% | -$6.98M |
|
|
497
PUT
PayPal
PYPL
$53.1B
| $13.2M | 0.04% |
56,300
+7,400
| +15% | +$1.53M |
|
498
Williams-Sonoma
WSM
$28.2B
| $13.1M | 0.04% |
257,870
-57,752
| -18% | -$2.96M |
|
499
Hudbay
HBM
$13.1B
| $13.1M | 0.04% |
1,872,149
-411,936
| -18% | -$2.33M |
|
|
IMGN
500
DELISTED
Immunogen Inc
IMGN
| $13.1M | 0.04% |
2,030,870
+391,428
| +24% | +$2.28M |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.